在COPD中的纳米材料:以金属有机框架为重点的新兴治疗和诊断前沿
Antonio Tiralosi1, Manuela Cambria1, Mariachiara Campanella2
1Volunteers Organization, Via re Martino 84a, 95126 Catania, Italy.
International journal of molecular sciences
|August 28, 2025
概括
金属有机框架 (MOF) 在治疗慢性阻塞性肺病 (COPD) 方面具有前景. 这些纳米颗粒为COPD治疗提供了有针对性的输送和改善的生物可用性,有可能克服当前治疗的局限性.
科学领域:
- 纳米医学
- 肺部医学
- 材料科学
背景情况:
- 慢性阻塞性肺病 (COPD) 在全球造成重大健康负担.
- 目前的疗法可以治疗症状,但无法治疗潜在的慢性炎症和氧化应激.
- 纳米粒子提供了克服COPD治疗药物输送局限性的新方法.
研究的目的:
- 审查近期临床前证据关于纳米粒子在COPD中的应用.
- 突出金属有机框架的治疗和诊断潜力.
- 讨论MOF与吸入药物交付相关的特性.
主要方法:
- 对COPD纳米颗粒的临床前研究的审查.
- 专注于用于药物输送的金属有机框架 (MOF).
- 对MOF属性的分析:生物相容性,药物加载和释放.
主要成果:
- 纳米颗粒可以增强向药物输送,调节免疫反应,并改善COPD模型的生物可用性.
- MOF具有适合吸入药物输送的特性,包括多孔性和功能性.
- 临床前数据表明MOF在COPD中具有治疗和诊断的潜力.
结论:
- 纳米颗粒,特别是MOF,代表了创新性COPD治疗的前沿.
- MOF提供了针对药物输送和呼吸系统中受控释放的多功能平台.
- 为了有效治疗COPD,需要对MOF的临床转化进行进一步的研究.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
COPD: Pathogenesis and Clinical Features
516
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
516
Chronic Obstructive Pulmonary Disease-V: Nursing Management
4.2K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
4.2K
COPD: Management Using Bronchodilators and Corticosteroids
305
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
305
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K


